The Race for Ozempic Alternatives: Unlocking the Future of Weight Loss Medication
Read Now!
Online
Log in
Explore
Drug Knowledgebase
Start here! Dig into essential drug information
Advanced Exploration
Categories & ATC Classifications
Pathways
Drug Reactions
Drug Classification
Drug Targets
Advanced Search
Target Sequence
Spectra Search
Pharmaco-omics
Chemical Structure
Data Library
Academic Downloads
Interaction Checker
Get More
Navigate to
DrugBank.com
to check out our commercial products, use cases and more!
DrugBank For Clinical Software
Clinical API
Clinical intelligence tool for your software
Features
Drug Search
Customizable drug search options
Drug-Drug Interaction Checker
Search for drug interactions with our API
Drug Allergy
Get drug allergy and cross sensitivities info
US Drug Labels
Integrate drug manufacturer information
Log in
Drugs
Targets
Pathways
Indications
Drugs
Drugs
Targets
Pathways
Indications
Log in or create an account for full access to this data.
Create Account
Log in
Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Drug Trials
Drug
Drug Name
Drug Description
Drug
Drug Name
Target
Type
Drug
Drug Name
Phase
Status
Count
DB12001
Abemaciclib
1
Terminated
1
DB05812
Abiraterone
1
Terminated
1
DB00316
Acetaminophen
1
Active Not Recruiting
1
DB11740
Adavosertib
1
Terminated
1
DB08916
Afatinib
1
Terminated
1
DB00062
Albumin human
1
Terminated
1
DB09495
Avobenzone
1
Terminated
1
DB05015
Belinostat
1
Terminated
1
DB00112
Bevacizumab
1
Terminated
1
DB01128
Bicalutamide
1
Terminated
1
DB00188
Bortezomib
1
Terminated
1
DB16741
Bortezomib D-mannitol
1
Terminated
1
DB06772
Cabazitaxel
1
Terminated
1
DB08875
Cabozantinib
1
Terminated
1
DB01101
Capecitabine
1
Terminated
1
DB00958
Carboplatin
1
Terminated
1
DB00482
Celecoxib
1
Terminated
1
DB05239
Cobimetinib
1
Terminated
1
DB12483
Copanlisib
1
Terminated
1
DB00987
Cytarabine
1
Active Not Recruiting
1
DB08912
Dabrafenib
1
Terminated
1
DB11963
Dacomitinib
1
Terminated
1
DB12941
Darolutamide
1
Terminated
1
DB01254
Dasatinib
1
Terminated
1
DB00694
Daunorubicin
1
Terminated
1
DB01234
Dexamethasone
1
Active Not Recruiting
1
DB01075
Diphenhydramine
1
Active Not Recruiting
1
DB00997
Doxorubicin
1
Terminated
1
DB11714
Durvalumab
1
Terminated
1
DB14598
Edetate calcium disodium anhydrous
1
Recruiting
1
DB00974
Edetic acid
1
Recruiting
1
DB13874
Enasidenib
1
Terminated
1
DB11986
Entrectinib
1
Terminated
1
DB08899
Enzalutamide
1
Terminated
1
DB00530
Erlotinib
1
Terminated
1
DB01590
Everolimus
1
Terminated
1
DB15223
Flotetuzumab
1
Active Not Recruiting
1
DB01073
Fludarabine
1
Active Not Recruiting
1
DB01073
Fludarabine
1
Suspended
1
DB00544
Fluorouracil
1
Terminated
1
DB01050
Ibuprofen
1
Active Not Recruiting
1
DB09054
Idelalisib
1
Terminated
1
DB00619
Imatinib
1
Terminated
1
DB06186
Ipilimumab
1
Completed
1
DB06186
Ipilimumab
1
Terminated
1
DB09078
Lenvatinib
1
Terminated
1
DB00650
Leucovorin
1
Terminated
1
DB12130
Lorlatinib
1
Terminated
1
DB00678
Losartan
1
Terminated
1
DB00688
Mycophenolate mofetil
1
Terminated
1
DB11828
Neratinib
1
Terminated
1
DB09035
Nivolumab
1
Completed
1
DB09035
Nivolumab
1
Terminated
1
DB09496
Octinoxate
1
Terminated
1
DB09074
Olaparib
1
Terminated
1
DB00526
Oxaliplatin
1
Terminated
1
DB01229
Paclitaxel
1
Terminated
1
DB09073
Palbociclib
1
Terminated
1
DB06603
Panobinostat
1
Terminated
1
DB16281
Pegcrisantaspase
1
Active Not Recruiting
1
DB09037
Pembrolizumab
1
Terminated
1
DB06366
Pertuzumab
1
Terminated
1
DB08901
Ponatinib
1
Terminated
1
DB00863
Ranitidine
1
Active Not Recruiting
1
DB08896
Regorafenib
1
Terminated
1
DB04974
Rimiducid
1
Withdrawn
1
DB08877
Ruxolitinib
1
Terminated
1
DB00877
Sirolimus
1
Terminated
2
DB00398
Sorafenib
1
Terminated
1
DB00566
Succimer
1
Recruiting
1
DB01268
Sunitinib
1
Terminated
1
DB08911
Trametinib
1
Terminated
1
DB05773
Trastuzumab emtansine
1
Terminated
1
DB00755
Tretinoin
1
Terminated
1
DB08881
Vemurafenib
1
Terminated
1
DB11581
Venetoclax
1
Terminated
1
DB08828
Vismodegib
1
Terminated
1
DB02546
Vorinostat
1
Terminated
1
DB00041
Aldesleukin
1 / 2
Completed
1
DB06616
Bosutinib
1 / 2
Completed
1
DB01008
Busulfan
1 / 2
Completed
1
DB00531
Cyclophosphamide
1 / 2
Completed
2
DB01234
Dexamethasone
1 / 2
Active Not Recruiting
1
DB01073
Fludarabine
1 / 2
Completed
3
DB05889
Inotuzumab ozogamicin
1 / 2
Completed
1
DB00888
Mechlorethamine
1 / 2
Completed
1
DB00688
Mycophenolate mofetil
1 / 2
Completed
2
DB15721
Natural Killer Cell
1 / 2
Completed
3
DB08901
Ponatinib
1 / 2
Active Not Recruiting
1
DB00073
Rituximab
1 / 2
Active Not Recruiting
1
DB00864
Tacrolimus
1 / 2
Completed
2
DB11581
Venetoclax
1 / 2
Active Not Recruiting
1
DB01076
Atorvastatin
2
Completed
1
DB01008
Busulfan
2
Active Not Recruiting
1
DB00242
Cladribine
2
Recruiting
1
DB00531
Cyclophosphamide
2
Active Not Recruiting
2
DB00531
Cyclophosphamide
2
Recruiting
1
DB00091
Cyclosporine
2
Completed
1
DB00091
Cyclosporine
2
Recruiting
1
DB00987
Cytarabine
2
Recruiting
1
DB01262
Decitabine
2
Active Not Recruiting
1
DB15223
Flotetuzumab
2
Withdrawn
1
DB01073
Fludarabine
2
Active Not Recruiting
2
DB01073
Fludarabine
2
Completed
2
DB12141
Gilteritinib
2
Recruiting
1
DB01177
Idarubicin
2
Recruiting
1
DB16620
Methopterin
2
Active Not Recruiting
1
DB00563
Methotrexate
2
Active Not Recruiting
1
DB06595
Midostaurin
2
Recruiting
1
DB00688
Mycophenolate mofetil
2
Active Not Recruiting
2
DB00688
Mycophenolate mofetil
2
Completed
2
DB00688
Mycophenolate mofetil
2
Recruiting
1
DB01132
Pioglitazone
2
Terminated
1
DB08901
Ponatinib
2
Active Not Recruiting
1
DB08901
Ponatinib
2
Recruiting
1
DB00877
Sirolimus
2
Completed
1
DB00877
Sirolimus
2
Recruiting
1
DB00864
Tacrolimus
2
Active Not Recruiting
2
DB00864
Tacrolimus
2
Completed
1
DB04572
Thiotepa
2
Active Not Recruiting
2
DB03754
Tromethamine
2
Active Not Recruiting
2
DB00135
Tyrosine
2
Terminated
1
DB11581
Venetoclax
2
Active Not Recruiting
1
DB11581
Venetoclax
2
Recruiting
1